Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 2,304 | 3,122 | 4,131 |
| Marketable Securities | 23 | 23 | 23 |
| Receivables | 279 | 368 | 699 |
| Inventories | 79 | 78 | 80 |
| Other current assets | 39 | 0 | 214 |
| TOTAL | $2,815 | $3,799 | $5,147 |
| Non-Current Assets | |||
| PPE Net | 55 | 57 | 99 |
| TOTAL | $55 | $57 | $99 |
| Total Assets | $2,870 | $3,856 | $5,208 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 48 | 44 | 40 |
| Accounts payable and accrued liabilities | 707 | 957 | 981 |
| Other current liabilities | N/A | N/A | 7 |
| TOTAL | $756 | $1,000 | $1,028 |
| Non-Current Liabilities | |||
| Long Term Debt | 715 | 705 | 812 |
| TOTAL | $715 | $705 | $812 |
| Total Liabilities | $1,471 | $1,705 | $1,840 |
| Shareholders' Equity | |||
| Common Shares | 10,728 | 10,588 | 8,444 |
| Retained earnings | -10,726 | -9,726 | -8,541 |
| Other shareholders' equity | 248 | 248 | 2,468 |
| TOTAL | $1,399 | $2,151 | $3,368 |
| Total Liabilities And Equity | $2,870 | $3,856 | $5,208 |